Skip to main content
. 2022 Apr 28;11(9):1488. doi: 10.3390/cells11091488

Figure 4.

Figure 4

CDN1163 improves hepatosteatosis in db/db mice. (A) Hematoxylin and eosin staining of liver sections for control and db/db mice with either vehicle or CDM1163. Scale bars, 100 μm. (B) Percentage of lipid droplet area. The value was calculated as lipid droplet area divided by tissue area excluding luminal structures (n = 5 for each group). (C) Serum AST levels (n = 9 for each group). (D) Serum ALT levels (n = 9 for each group). (E) Serum fasted TG levels (Ctrl+veh, n = 4; Ctrl+CDN, n = 4; Db+veh, n = 5; Db+CDN, n = 4). (F) Serum TC levels (n = 9 for each group). Error bars represent SEM. * p < 0.05, ** p < 0.01, **** p < 0.0001 vs. Db+veh. AST, aspartate aminotransferase; ALT, alanine aminotransferase; Db, db/db mice; TG, triglyceride; TC, total cholesterol; NS, not significant.